Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis

NCT00595790 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT00595790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00595790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis
Lead sponsor
Valneva Austria GmbH
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
November 30, 2007
Enrollment
374 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis